News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Kite Pharma
NEWS
JOBS
IN THE PRESS
NEWS
Drug Development
Investors Beware: Thin CAR-T Data Could Make or Break Juno and Kite Pharma
September 22, 2016
·
2 min read
Biotech Bay
Taking a Look at 3 Stocks That are Better Buys Than Gilead
September 8, 2016
·
2 min read
Bio NC
7 Biotech Stocks Investors Should Keep Their Eye On in 2017
August 3, 2016
·
3 min read
Drug Development
Kite Pharma and Juno’s R&D Strategy to Reshape Cancer Treatment
June 21, 2016
·
2 min read
Business
Kite Pharma Opens Up New T-Cell Therapy Manufacturing Plant in California
June 21, 2016
·
2 min read
Biotech Bay
3 Depressed Biotechs that Investors with a Long-Term Perspective Should Buy Right Now
April 11, 2016
·
3 min read
Drug Development
Kite Pharma’s CEO On Cancer-Killing T-Cells: “This Is A Revolution”
February 29, 2016
·
1 min read
Policy
Onco-Immunology Companies like Juno, Novartis AG, Kite Pharma Struggle to Mass Produce Custom Cancer Therapies
October 30, 2015
·
4 min read
Business
SoCal’s Kite Pharma Strikes Cancer Deal Worth $535 Million+ with Alpine Immune Sciences
October 27, 2015
·
3 min read
AWARDS
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Business
Kite Pharma To Report First Quarter 2017 Financial Results On May 8, 2017
May 1, 2017
·
1 min read
Drug Development
Kite Pharma Presents Promising Preclinical Data From KITE-585, A Fully Human Anti-BCMA CAR T-Cell Product Candidate At The 2017 AACR Annual Meeting
April 5, 2017
·
4 min read
Biotech Beach
Kite Pharma Highlights Publication On Breakthrough In Generating Fully Functioning T Cells From Hematopoietic Precursor Cells By Leading Researchers At UCLA
April 4, 2017
·
3 min read
Policy
Kite Pharma Presents Ongoing Response Rate In Plenary Session From Its Pivotal CAR-T Trial Of Axicabtagene Ciloleucel In Patients With Aggressive Non-Hodgkin Lymphoma At The 2017 AACRh Annual Meeting
April 3, 2017
·
7 min read
Drug Development
Kite Pharma To Present Two Plenary Presentations From The ZUMA-1 Pivotal Trial Of Axicabtagene Ciloleucel At The 2017 AACR Annual Meeting
March 30, 2017
·
6 min read
Business
Kite Pharma Announces Appointment Of Renowned Cancer Researcher, Owen N. Witte, M.D., To Its Board Of Directors
March 16, 2017
·
5 min read
Drug Development
Kite Pharma Highlights Publication From NCI Demonstrating Durable Complete Remissions In Patients With Relapsed/Refractory Non-Hodgkin Lymphoma Following Low Dose Conditioning Chemotherapy And Anti-CD19 CAR T-Cell Therapy
March 15, 2017
·
4 min read
Biotech Beach
Kite Pharma Announces Closing Of Public Offering Of Common Stock And Full Exercise Of Underwriters’ Option To Purchase Additional Shares
March 8, 2017
·
3 min read
Business
Kite Pharma Release: Richard L. Wang Named Chief Executive Officer Of Fosun Kite Biotechnology Co., Ltd., A Joint Venture To Lead Development Of Axicabtagene Ciloleucel And Other Engineered T-Cell Therapies For Treatment Of Cancers In China
March 6, 2017
·
3 min read
Biotech Beach
Kite Pharma Announces Commencement Of Public Offering Of Common Stock
March 2, 2017
·
3 min read
